Cloud Pharmaceuticals

Cloud Pharmaceuticals expands advisory board

Thursday, July 23, 2015

Cloud Pharmaceuticals, a therapeutics company focused on cloud-based drug design and development, has added members to its advisory board. The board is comprised of four leaders from industry and academia with experience in complex molecular and macromolecular systems, biophysics, translational research and drug discovery and development. The advisors collaborate with Cloud Pharmaceuticals’ board of directors to provide insight on needs and opportunities within the pharmaceutical industry.

[Read More]

Cloud Pharmaceuticals ratifies board of directors

Friday, November 7, 2014

Cloud Pharmaceuticals, a therapeutics company focused on cloud-based drug design and development, has ratified its board of directors. Members of the board include Cloud Pharmaceuticals chairman and CEO Ed Addison, chief scientific officer Shahar Keinan, Ph.D., and chief information officer Lawrence Husick. Other members of the board include:

[Read More]